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Abstract. Lymph nodes play a central role in metastatic
cancer spread and are a key clinical assessment target.
Abnormal node vascularization, morphology, and size
may be indicative of disease but can be difficult to visualize
with sufficient accuracy using existing clinical imaging
modalities. To explore the potential utility of photoacoustic
imaging for the assessment of lymph nodes, images of ex
vivo samples were obtained at multiple wavelengths using
a high-resolution three-dimensional photoacoustic scan-
ner. These images showed that hemoglobin based con-
trast reveals nodal vasculature and lipid-based contrast
reveals the exterior node size, shape, and boundary integ-
rity. These two sources of complementary contrast may
allow indirect observation of cancer, suggesting a future
role for photoacoustic imaging as a tool for the clinical
assessment of lymph nodes. © 2015 Society of Photo-Optical
Instrumentation Engineers (SPIE) [DOI: 10.1117/1.JBO.20.5.050504]
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1 Introduction
Lymph nodes are a foremost site of metastasis in many cancers,
and establishing their level of involvement is important for dis-
ease staging, prognosis, and treatment planning.1,2 Extranodal
spread—breaching of the lymph node boundary by cancer—
and neoangiogenesis can be indicators of cancer but are difficult
to detect in vivo.2 Established clinical imaging modalities such
as contrast-enhanced computed tomography and magnetic res-
onance imaging (MRI) can provide an estimate of the size of a
lymph node. However, their inability to identify small cancerous
deposits, reveal the detailed structure of the node, or visualize
the internal vasculature limits diagnostic utility.3 Many clinical
situations, therefore, require histopathological assessment fol-
lowing biopsy, which is necessarily invasive and can lead to
complications.3
Photoacoustic imaging is an emerging modality4 that may be
able to overcome some of the limitations of existing clinical im-
aging methods. Previous studies have demonstrated the poten-
tial to visualize cancer cells directly in excised human and
animal nodes by exploiting the contrast provided by endogenous
melanin5 and an exogenous contrast agent6 respectively.
Sentinel lymph nodes have also been imaged macroscopically
in small animals with contrast agents flooding the node.7
While imaging cancer cells directly is clearly desirable, it is
challenging in general because without exogenous contrast
agents, most cancer cells (save for melanocytes) do not contain
molecules that exhibit significant optical absorption.
In this study, a different approach, high-resolution photo-
acoustic imaging of human lymph nodes using intrinsic contrast
based on hemoglobin (Hb) and lipids, is explored. Contrast is
correspondingly derived from internal vasculature and the fatty
layer surrounding the node. This approach may allow indirect
observation of cancer, for example by visualizing neoangiogen-
esis and revealing the distortion of a node boundary owing to
internal tumor spreading.
2 Materials and Methods
Two formalin-fixed, macroscopically normal human mesenteric
lymph nodes, “A” and “B,” were imaged with a previously
described photoacoustic imaging scanner,8 operating in tomog-
raphy mode as shown in Fig. 1. The system comprises a wide-
field optical excitation source and an ultrasound detection sys-
tem utilizing a planar Fabry–Perot polymer thin film sensor. The
transduction mechanism of the sensor is one in which acousti-
cally induced changes in its optical thickness produce a corre-
sponding reflectivity modulation which is detected using a
continuous-wave interrogation laser beam focused on the
plane of the sensor. The interrogation beam is optically scanned
point-by-point over the surface of the sensor in order to map the
spatial distribution of the incident acoustic field in two dimen-
sions. A three-dimensional (3-D) photoacoustic image is then
reconstructed from these measurements using a fast k-space
algorithm.8 The system can provide a lateral field-of-view
(FOV) of 20 mm × 20 mm, a penetration depth in tissue of
approximately 10 mm, and a spatial resolution in the range 50
to 150 μm depending on depth and lateral position.8
The lymph nodeswere placed in acoustic contact with the sen-
sor, submerged in either water or 1% intralipid solution, the latter
creating a tissue-like scattering medium. The excitation source
was a fiber-coupled, 30 Hz, wavelength-tunable optical paramet-
ric oscillator (OPO) laser system (Spitlight 600, InnoLas Laser
GmbH, Krailling, Germany). The maximum fluence incident
on the node surface was estimated to be 8 mJ∕cm2 per pulse.
Althoughmeasurementsweremade in forward-mode for conven-
ience, the transparent nature of the sensor allows convenient
backward-mode operation as required for clinical use.8
Nodes were first imaged at excitation wavelengths of
530 nm, where optical absorption by Hb is strong,9 and at
1210 nm, at which there is a prominent lipid absorption peak.10
For convenient visualization, images of Hb and lipid were fused
together by overlaying the Hb image on the lipid image and
applying (to the Hb image) a level of opacity proportional to
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the image intensity. Node A only was then imaged again at
1210 nm and at 920 nm, a weaker lipid absorption peak, in
order to compare the potential of imaging lipid structures at
these two wavelengths. For comparison with the photoacoustic
images, both nodes were also imaged using a clinical ultrasound
system (ACUSON S2000, Siemens Healthcare, with a 18L6HD
transducer) operated at 17 MHz, and a clinical 3T MRI system
(Achieva, Philips Medical Systems) using the fat-sensitive com-
ponent of an mDIXON sequence.
3 Results and Discussion
Figure 2 shows the photoacoustic images of both nodes acquired
using excitation wavelengths of 530 and 1210 nm. For node A,
fly-through movies showing successive individual x − y slices
for each wavelength are available online and best illustrate
the 3-D structure of the node. For both nodes, the 530 nm
data show the blood vessels and the 1210 nm data show the
fat surrounding the nodes. The vasculature within each of the
nodes appears to be consistent with normal node physiology
and there are apparent commonalities between the two nodes
in terms of the size, structure, and distribution of the vessels.
As shown in Fig. 2, MRI is able to detect the node boundary
based on fat contrast but with poor resolution and the ultrasound
image reveals (with relatively low-resolution) the vessels as well
as the fat. The photoacoustic images allow specific identification
of the source of the contrast for both Hb and lipid owing to the
spectral specificity of the technique.
The results show that it is possible to use photoacoustic im-
aging to provide intrinsically coregistered images of Hb and lip-
ids in human lymph nodes and to interrogate the lipid with
striking clarity. The presence of the node boundary in the images
provides a useful spatial context for the blood vessel distribution
and it is hypothesized that it may also allow identification of
small changes in nodal structure due to malignant deposits.
While the lipid boundary was detectable at 1210 nm in these
experiments, the in vivo penetration depth achievable at this
wavelength is likely to be limited due to strong water absorption.
Experiments were, therefore, also performed at 920 nm, another
lipid peak, at which both water and lipid absorption are signifi-
cantly lower permitting greater penetration depth. Figure 3
shows the depth-resolved cross-sectional photoacoustic images
of node A acquired in water using wavelengths of 920 and
1210 nm. Also shown is a graph of the near-infrared (NIR)
absorption spectra of water, lipids, and Hb.9–11 The images show
near identical features in the lipid around the node at both wave-
lengths. Although data are shown for selected slices only, the lipid
is visible through the full depth of the node (∼5 mm) at both
wavelengths making it possible to delineate the entire boundary.
The signal-to-noise ratio (SNR) at 920 nm is lower than at
1210 nm, as expected due to the significantly higher absorption
at 1210 nm and the modest penetration depths (<6 mm)
involved in these experiments. At greater depths in vivo, it is
anticipated that 920 nm will yield a higher SNR than 1210 nm.
Consider a tissue composed of 74% water, 1% blood, and 25%
fat. Using typical values for the absorption coefficient, μa, of
these chromophores,9,10 and the reduced scattering coefficient,
Fig. 1 Experimental setup for imaging lymph node samples.
Fig. 2 Images of two lymph node samples (node A and node B) acquired using macroscopic photography,
clinical 3T magnetic resonance imaging (MRI), ultrasound (17 MHz), and photoacoustic imaging. The
photoacoustic images are maximum intensity projections of the three-dimensional (3-D) image datasets
obtained at 530 nm [red: hemoglobin (Hb)] and 1210 nm (gray: lipid), fused together and visualized at two
perpendicular orientations. The photoacoustic images of node A were obtained with step sizes of 50 and
100 μm for the lipid and Hb data, respectively, with a field-of-view (FOV) of 9 × 11 mm. A fly-throughmovie
of node A can be viewed online (supplementary information online: Video 1, MOV, 6768 KB). The images of
node B were obtained with 200-μm step sizes with an FOV of 10 × 11 mm. The sensor bandwidth (−3 dB)
for both datasets was 31 MHz [URL: http://dx.doi.org/10.1117/1.JBO.20.5.050504.1].
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μ 0s, of fatty tissue,
9 the effective attenuation coefficient for the
tissue can be calculated as μeff ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
3μaðμa þ μ 0sÞ
p
. Transmittance
at depth d can then be estimated by TðdÞ ¼ e−μeffd. Using val-
ues of 0.1 and 1.7 cm−1 for μa and 12.2 and 10.2 cm−1 for μ
0
s,
for 920 and 1210 nm, respectively, μeff is calculated to be 1.9
and 7.8 cm−1. Using this model, at 7 mm (approximate mini-
mum lymph node depth), the transmittance at 920 nm is
17% and at 1210 nm it is 1.2%. This corresponds approximately
to the difference in absorption of lipids at the two wavelengths,
therefore, the greater loss in light due to attenuation in the sur-
rounding medium is compensated by the increased absorption
attained at the higher wavelength and the predicted SNR at
the two wavelengths is similar at this depth. Beyond this
depth, it becomes exponentially more beneficial to use 920 nm.
For example, at a depth of 12.5 mm, the calculated transmittance
is 4.5% at 920 nm and 0.034% at 1210 nm which, correcting for
the difference in absorption, leads to a predicted 10-fold
improvement in SNR at 920 nm.
4 Conclusion
Photoacoustic imaging has been used to obtain high-resolution
3-D images of the structure and internal vasculature of human
lymph nodes based on Hb and lipid contrast. Compared with
clinical ultrasound and MRI, the photoacoustic images exhibit
high resolution and contrast as well as providing chromophore
specificity. Lipid imaging was shown to be possible at 920 and
1210 nm excitation wavelengths. SNR at 920 nm was lower than
that at 1210 nm as expected for the penetration depths relevant
(<6 mm) to this study. However, calculations suggest that, for
greater depths, 920 nm may provide a higher SNR in vivo owing
to weaker attenuation by background tissues. As well as being
relevant to photoacoustic lymph node imaging, this finding may
allow visualization of other lipid rich structures such as nerves at
depths beyond that achievable using the more commonly used
1210 nm lipid excitation wavelength.12 It is concluded that photo-
acoustic imaging with endogenous contrast has the potential to
assess cancer in the human lymph node by providing images of
node vasculature andmorphology. Further work will be undertaken
to establish the clinical utility of the approach by imaging nodes
with known malignant deposits and by carrying out in vivo studies.
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Fig. 3 (a) Photoacoustic images of node A obtained at 1210 and 920 nm and (b) near-infrared (NIR)
absorption spectra of Hb, water, and lipids. The images are cross-sectional slices at selected depths
as indicated. The images were obtained with a step size of 100 μm, with an FOV of 9 × 9 mm. The sensor
bandwidth (−3 dB) was 40 MHz.
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